Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NUTRItional Adequacy Therapeutic Enhancement in the Critically Ill: A Randomized Double Blind, Placebo-controlled Trial of the Motilin Receptor Agonist GSK962040. The NUTRIATE Study

NCT01934192 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01934192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01934192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NUTRItional Adequacy Therapeutic Enhancement in the Critically Ill: A Randomized Double Blind, Placebo-controlled Trial of the Motilin Receptor Agonist GSK962040. The NUTRIATE Study
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Terminated
Start date
April 4, 2014
Completion date
July 8, 2016
Enrollment
91 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

gastroparesis